Sr One Capital Partners I, LP insider trades: eFFECTOR Therapeutics (EFTR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sr One Capital Partners I, LP reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 27, 2023 | EFTR | ↓ Sell | 430,578 | $0.61 | $261K | See Note 2 | Nov 29, 2023 (2d) |
| Nov 27, 2023 | EFTR | ↓ Sell | 178,585 | $0.61 | $108K | See Note 3 | Nov 29, 2023 (2d) |
| May 11, 2023 | ACLX | ↓ Sell | 638,417 | $45.01 | $28.7M | See Note 2 | May 15, 2023 (4d) |
| May 11, 2023 | ACLX | ↓ Sell | 374,416 | $45.01 | $16.9M | See Note 3 | May 15, 2023 (4d) |
| Dec 20, 2022 | DSGN | ↑ Buy | 900,000 | $8.42 | $7.6M | Direct | Dec 20, 2022 (0d) |
| Feb 8, 2022 | ACLX | ↑ Buy | 1,666,667 | $15.00 | $25.0M | Indirect | Feb 10, 2022 (2d) |
| Mar 30, 2021 | DSGN | ↑ Buy | 250,000 | $20.00 | $5.0M | Direct | Apr 1, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Sr One Capital Partners I, LP's insider trades
Sr One Capital Partners I, LP is a 10% owner of eFFECTOR Therapeutics (EFTR). Since Mar 30, 2021, it has reported 3 open-market purchases worth $37.6M and 4 sales worth $46.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EFTR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.